These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11125029)

  • 1. DNA-interactive anticancer aza-anthrapyrazoles: biophysical and biochemical studies relevant to the mechanism of action.
    Sissi C; Moro S; Richter S; Gatto B; Menta E; Spinelli S; Krapcho AP; Zunino F; Palumbo M
    Mol Pharmacol; 2001 Jan; 59(1):96-103. PubMed ID: 11125029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel 9-aza-anthrapyrazole effective against human prostatic carcinoma xenografts.
    Supino R; Polizzi D; Pavesi R; Pratesi G; Guano F; Capranico G; Palumbo M; Sissi C; Richter S; Beggiolin G; Menta E; Pezzoni G; Spinelli S; Torriani D; Carenini N; Dal Bo L; Facchinetti F; Tortoreto M; Zunino F
    Oncology; 2001; 61(3):234-42. PubMed ID: 11574780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topoisomerase II inhibition and cytotoxicity of the anthrapyrazoles DuP 937 and DuP 941 (Losoxantrone) in the National Cancer Institute preclinical antitumor drug discovery screen.
    Leteurtre F; Kohlhagen G; Paull KD; Pommier Y
    J Natl Cancer Inst; 1994 Aug; 86(16):1239-44. PubMed ID: 8040892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aza-bioisosteres of 9, 10-anthracenedione: a modulation of DNA sequence specificity.
    Sissi C; Capranico G; Menta E; Palumbo M
    Mol Pharmacol; 1996 Oct; 50(4):838-45. PubMed ID: 8863828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor AZA-anthrapyrazoles: biophysical and biochemical studies on 8- and 9-aza regioisomers.
    Sissi C; Leo E; Moro S; Capranico G; Mancia A; Menta E; Krapcho AP; Palumbo M
    Biochem Pharmacol; 2004 Feb; 67(4):631-42. PubMed ID: 14757163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity.
    Gatto B; Zagotto G; Sissi C; Cera C; Uriarte E; Palù G; Capranico G; Palumbo M
    J Med Chem; 1996 Aug; 39(16):3114-22. PubMed ID: 8759632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A structure-based 3D-QSAR study of anthrapyrazole analogues of the anticancer agents losoxantrone and piroxantrone.
    Liang H; Wu X; Guziec LJ; Guziec FS; Larson KK; Lang J; Yalowich JC; Hasinoff BB
    J Chem Inf Model; 2006; 46(4):1827-35. PubMed ID: 16859314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topoisomerase II DNA cleavage stimulation, DNA binding activity, cytotoxicity, and physico-chemical properties of 2-aza- and 2-aza-oxide-anthracenedione derivatives.
    De Isabella P; Palumbo M; Sissi C; Capranico G; Carenini N; Menta E; Oliva A; Spinelli S; Krapcho AP; Giuliani FC
    Mol Pharmacol; 1995 Jul; 48(1):30-8. PubMed ID: 7623772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical properties, cytotoxic activity and topoisomerase II inhibition of 2,3-diaza-anthracenediones.
    de Isabella P; Palumbo M; Sissi C; Carenini N; Capranico G; Menta E; Oliva A; Spinelli S; Krapcho AP; Giuliani FC; Zunino F
    Biochem Pharmacol; 1997 Jan; 53(2):161-9. PubMed ID: 9037248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of bis-substituted 2-aza-anthracenedione regioisomers to DNA: effects of the relative positioning of the side chains.
    Sissi C; Moro S; Zagotto G; Ellis M; Krapcho AP; Menta E; Palumbo M
    Anticancer Drug Des; 1999 Jun; 14(3):265-74. PubMed ID: 10500501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-binding preferences of bisantrene analogues: relevance to the sequence specificity of drug-mediated topoisomerase II poisoning.
    Sissi C; Bolgan L; Moro S; Zagotto G; Bailly C; Menta E; Capranico G; Palumbo M
    Mol Pharmacol; 1998 Dec; 54(6):1036-45. PubMed ID: 9855632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amido analogs of mitoxantrone: physico-chemical properties, molecular modeling, cellular effects and antineoplastic potential.
    Zagotto G; Moro S; Uriarte E; Ferrazzi E; Palù G; Palumbo M
    Anticancer Drug Des; 1997 Mar; 12(2):99-112. PubMed ID: 9113065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence selectivity of topoisomerase II DNA cleavage stimulated by mitoxantrone derivatives: relationships to drug DNA binding and cellular effects.
    De Isabella P; Capranico G; Palumbo M; Sissi C; Krapcho AP; Zunino F
    Mol Pharmacol; 1993 May; 43(5):715-21. PubMed ID: 8388987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational drug determinants of the sequence specificity of drug-stimulated topoisomerase II DNA cleavage.
    Capranico G; Palumbo M; Tinelli S; Mabilia M; Pozzan A; Zunino F
    J Mol Biol; 1994 Jan; 235(4):1218-30. PubMed ID: 8308885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of DNA reactivity and cytotoxicity of a new class of anticancer agents: aza-anthracenediones.
    Hazlehurst LA; Krapcho AP; Hacker MP
    Cancer Lett; 1995 May; 91(1):115-24. PubMed ID: 7750086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of site-specific topoisomerase II-mediated DNA cleavage by an N-methylpyrrolecarboxamide-anilinoacridine conjugate: relation to DNA binding.
    Fossé P; René B; Saucier JM; Hénichart JP; Waring MJ; Colson P; Houssier C; Bailly C
    Biochemistry; 1994 Aug; 33(33):9865-74. PubMed ID: 8060993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, DNA binding, topoisomerase II inhibition and cytotoxicity of two guanidine-containing anthracene-9,10-diones.
    Routier S; Bernier JL; Catteau JP; Riou JF; Bailly C
    Anticancer Drug Des; 1998 Jul; 13(5):407-15. PubMed ID: 9702207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activity of anthrapyrazoles derivatives as potential antitumor agents.
    Wang J; Zhao H; Luo Z; Wang Z; Zhang Y; Zhao J
    Med Chem; 2014; 10(8):772-7. PubMed ID: 24773347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor potential of aza-bioisosterism in anthracenedione-based drugs.
    Sissi C; Palumbo M
    Curr Top Med Chem; 2004; 4(2):219-30. PubMed ID: 14754455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase II.
    Capranico G; De Isabella P; Tinelli S; Bigioni M; Zunino F
    Biochemistry; 1993 Mar; 32(12):3038-46. PubMed ID: 8384486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.